10, 2014/PRNewswire/ –Actavis plc, a respected global specialty pharmaceutical organization, today announced thatMaria Teresa Hiladowill join the Company, effectiveDecember 8, 2014, as Chief Financial Officer. Ms. Hilado brings a lot more than 26 years of global finance experience to the positioning, and will be centered at the Organization'sParsippany, NJ, U.S. Administrative Headquarters. She shall succeedR. Todd Joyce, who’ll remain withActavisthrough early 2015 to aid the transition. ‘Tessa can be an experienced, finance head whose nearly three years in financial leadership roles at some of the world's leading multinational corporations will be invaluable toActavisas we continue our evolution as one of the fastest-growing & most dynamic pharmaceutical companies in the world,’ saidBrent Saunders,ActavisCEO and President.Affytrac can be used by life research companies across the world to resolve their toughest EH&S issues, said Calhoun.
Advances in genomic techniques help understand cancer in cellular and molecular level Cancer tumor is a complex disease and only thanks to advances in genomic techniques have experts begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in malignancy cells. This understanding is an integral prerequisite for developing effective treatment strategies. One very clear example of this is breast cancer. It has long been known that hormones such as progesterone and oestrogen encourage the proliferation of tumor cells.